{
  "url": "https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&ff=20251105032325&v=2.18.0.post22+67771e2",
  "title": "Hypoxia induces histone clipping and H3K4me3 loss in neutrophil progenitors resulting in long-term impairment of neutrophil immunity - PubMed",
  "description": "The long-term impact of systemic hypoxia resulting from acute respiratory distress syndrome (ARDS) on the function of short-lived innate immune cells is unclear. We show that patients 3-6 months after recovering from ARDS have persistently impaired circulating neutrophil effector functions and an in …",
  "links": [
    "https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&ff=20251105032325&v=2.18.0.post22+67771e2"
  ],
  "image": "https://cdn.ncbi.nlm.nih.gov/pubmed/persistent/pubmed-meta-image-v2.jpg",
  "content": "<div>\n      <div>\n          <div>\n    <div>\n<p><span>. </span><span>2025 Nov;26(11):1903-1915.</span>\n    </p></div>\n      <p><span>\n        doi: 10.1038/s41590-025-02301-9.\n      </span>\n      <span>\n        Epub 2025 Oct 28.\n      </span>\n          </p></div>\n          <div>\n    <p><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Sadiku+P&amp;cauthor_id=41152617\">Pranvera Sadiku</a><sup><span> </span><a target=\"_blank\" title=\"Contributed equally\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-equal-contrib-explanation\">#</a></sup><sup><span> </span><a target=\"_blank\" title=\"Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-1\">\n                1\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Ortmann+BM&amp;cauthor_id=41152617\">Brian M Ortmann</a><sup><span> </span><a target=\"_blank\" title=\"Contributed equally\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-equal-contrib-explanation\">#</a></sup><sup><span> </span><a target=\"_blank\" title=\"Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Department of Medicine, University of Cambridge, Cambridge, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-2\">\n                2\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Wit+N&amp;cauthor_id=41152617\">Niek Wit</a><sup><span> </span><a target=\"_blank\" title=\"Contributed equally\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-equal-contrib-explanation\">#</a></sup><sup><span> </span><a target=\"_blank\" title=\"Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Department of Medicine, University of Cambridge, Cambridge, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-2\">\n                2\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Negishi+Y&amp;cauthor_id=41152617\">Yutaka Negishi</a><sup><span> </span><a target=\"_blank\" title=\"Contributed equally\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-equal-contrib-explanation\">#</a></sup><sup><span> </span><a target=\"_blank\" title=\"Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-3\">\n                3\n              </a><span> </span><a target=\"_blank\" title=\"Department of Cell Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, the Netherlands.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-4\">\n                4\n              </a><span> </span><a target=\"_blank\" title=\"Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-5\">\n                5\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Coelho+P&amp;cauthor_id=41152617\">Patricia Coelho</a><sup><span> </span><a target=\"_blank\" title=\"Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-1\">\n                1\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Zhang+A&amp;cauthor_id=41152617\">Ailiang Zhang</a><sup><span> </span><a target=\"_blank\" title=\"Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-1\">\n                1\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Pednekar+C&amp;cauthor_id=41152617\">Chinmayi Pednekar</a><sup><span> </span><a target=\"_blank\" title=\"CRUK Scotland Centre, IGC, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-6\">\n                6\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Howden+AJM&amp;cauthor_id=41152617\">Andrew J M Howden</a><sup><span> </span><a target=\"_blank\" title=\"Division of Cell Signalling and Immunology, University of Dundee, Dundee, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-7\">\n                7\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Griffith+DM&amp;cauthor_id=41152617\">David M Griffith</a><sup><span> </span><a target=\"_blank\" title=\"The Usher Institute, University of Edinburgh, Royal Infirmary of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-8\">\n                8\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Seear+R&amp;cauthor_id=41152617\">Rachel Seear</a><sup><span> </span><a target=\"_blank\" title=\"Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Department of Medicine, University of Cambridge, Cambridge, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-2\">\n                2\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Kindrick+JD&amp;cauthor_id=41152617\">Jessica D Kindrick</a><sup><span> </span><a target=\"_blank\" title=\"NDM Research Building, Nuffield Department of Medicine, University of Oxford, Oxford, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-9\">\n                9\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Mengede+J&amp;cauthor_id=41152617\">Janine Mengede</a><sup><span> </span><a target=\"_blank\" title=\"Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-3\">\n                3\n              </a><span> </span><a target=\"_blank\" title=\"Department of Cell Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, the Netherlands.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-4\">\n                4\n              </a><span> </span><a target=\"_blank\" title=\"Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-5\">\n                5\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Cooper+G&amp;cauthor_id=41152617\">George Cooper</a><sup><span> </span><a target=\"_blank\" title=\"Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-1\">\n                1\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Morrison+T&amp;cauthor_id=41152617\">Tyler Morrison</a><sup><span> </span><a target=\"_blank\" title=\"Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-1\">\n                1\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Watts+ER&amp;cauthor_id=41152617\">Emily R Watts</a><sup><span> </span><a target=\"_blank\" title=\"Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-1\">\n                1\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Shimeld+BT&amp;cauthor_id=41152617\">Benjamin T Shimeld</a><sup><span> </span><a target=\"_blank\" title=\"Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-1\">\n                1\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Reyes+L&amp;cauthor_id=41152617\">Leila Reyes</a><sup><span> </span><a target=\"_blank\" title=\"Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-1\">\n                1\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Mirchandani+AS&amp;cauthor_id=41152617\">Ananda S Mirchandani</a><sup><span> </span><a target=\"_blank\" title=\"Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-1\">\n                1\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Arienti+S&amp;cauthor_id=41152617\">Simone Arienti</a><sup><span> </span><a target=\"_blank\" title=\"Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-1\">\n                1\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Xu+X&amp;cauthor_id=41152617\">Xiang Xu</a><sup><span> </span><a target=\"_blank\" title=\"Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-1\">\n                1\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Thomson+A&amp;cauthor_id=41152617\">Alexander Thomson</a><sup><span> </span><a target=\"_blank\" title=\"Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-1\">\n                1\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Brenes+AJ&amp;cauthor_id=41152617\">Alejandro J Brenes</a><sup><span> </span><a target=\"_blank\" title=\"Division of Cell Signalling and Immunology, University of Dundee, Dundee, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-7\">\n                7\n              </a><span> </span><a target=\"_blank\" title=\"Centre for Gene Regulation and Expression, University of Dundee, Dundee, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-10\">\n                10\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Turton+HA&amp;cauthor_id=41152617\">Helena A Turton</a><sup><span> </span><a target=\"_blank\" title=\"Division of Clinical Medicine, University of Sheffield, Sheffield, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-11\">\n                11\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Dowey+R&amp;cauthor_id=41152617\">Rebecca Dowey</a><sup><span> </span><a target=\"_blank\" title=\"Division of Clinical Medicine, University of Sheffield, Sheffield, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-11\">\n                11\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Hull+RC&amp;cauthor_id=41152617\">Rebecca C Hull</a><sup><span> </span><a target=\"_blank\" title=\"Division of Clinical Medicine, University of Sheffield, Sheffield, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-11\">\n                11\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Davidson-Smith+H&amp;cauthor_id=41152617\">Hazel Davidson-Smith</a><sup><span> </span><a target=\"_blank\" title=\"MRC Human Genetics Unit, MRC IGC, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-12\">\n                12\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=McLaren+A&amp;cauthor_id=41152617\">Amy McLaren</a><sup><span> </span><a target=\"_blank\" title=\"NHS Lothian, Respiratory Medicine, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-13\">\n                13\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Deans+A&amp;cauthor_id=41152617\">Andrew Deans</a><sup><span> </span><a target=\"_blank\" title=\"NHS Lothian, Respiratory Medicine, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-13\">\n                13\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Choudhury+G&amp;cauthor_id=41152617\">Gourab Choudhury</a><sup><span> </span><a target=\"_blank\" title=\"NHS Lothian, Respiratory Medicine, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-13\">\n                13\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Doverman+K&amp;cauthor_id=41152617\">Katherine Doverman</a><sup><span> </span><a target=\"_blank\" title=\"Edinburgh Critical Care Research Group, NHS Lothian, Royal Infirmary of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-14\">\n                14\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Hope+D&amp;cauthor_id=41152617\">David Hope</a><sup><span> </span><a target=\"_blank\" title=\"Edinburgh Critical Care Research Group, NHS Lothian, Royal Infirmary of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-14\">\n                14\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Vick+O&amp;cauthor_id=41152617\">Oliver Vick</a><sup><span> </span><a target=\"_blank\" title=\"Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-1\">\n                1\n              </a><span> </span><a target=\"_blank\" title=\"Altitude Physiology Expeditions (APEX), Sheffield, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-15\">\n                15\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Woodhead+A&amp;cauthor_id=41152617\">Alastair Woodhead</a><sup><span> </span><a target=\"_blank\" title=\"Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-1\">\n                1\n              </a><span> </span><a target=\"_blank\" title=\"Altitude Physiology Expeditions (APEX), Sheffield, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-15\">\n                15\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Petrie+I&amp;cauthor_id=41152617\">Isla Petrie</a><sup><span> </span><a target=\"_blank\" title=\"Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-1\">\n                1\n              </a><span> </span><a target=\"_blank\" title=\"Altitude Physiology Expeditions (APEX), Sheffield, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-15\">\n                15\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Green+S&amp;cauthor_id=41152617\">Suzanne Green</a><sup><span> </span><a target=\"_blank\" title=\"Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-1\">\n                1\n              </a><span> </span><a target=\"_blank\" title=\"Altitude Physiology Expeditions (APEX), Sheffield, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-15\">\n                15\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Rzechorzek+NM&amp;cauthor_id=41152617\">Nina M Rzechorzek</a><sup><span> </span><a target=\"_blank\" title=\"Altitude Physiology Expeditions (APEX), Sheffield, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-15\">\n                15\n              </a><span> </span><a target=\"_blank\" title=\"MRC Laboratory of Molecular Biology, Cambridge, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-16\">\n                16\n              </a><span> </span><a target=\"_blank\" title=\"Department of Engineering, University of Cambridge, Cambridge, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-17\">\n                17\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Turtle+L&amp;cauthor_id=41152617\">Lance Turtle</a><sup><span> </span><a target=\"_blank\" title=\"Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-18\">\n                18\n              </a><span> </span><a target=\"_blank\" title=\"Tropical and Infectious Disease Unit, Liverpool University Hospitals NHS Foundation Trust (member of Liverpool Health Partners), Liverpool, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-19\">\n                19\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Openshaw+PJM&amp;cauthor_id=41152617\">Peter J M Openshaw</a><sup><span> </span><a target=\"_blank\" title=\"Respiratory Infection Section, National Heart and Lung Institute, Imperial College London, London, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-20\">\n                20\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Semple+MG&amp;cauthor_id=41152617\">Malcolm G Semple</a><sup><span> </span><a target=\"_blank\" title=\"Health Protection Research Unit in Emerging and Zoonotic Infections, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-18\">\n                18\n              </a><span> </span><a target=\"_blank\" title=\"Respiratory Department, Liverpool Institute of Child Health and Wellbeing, Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-21\">\n                21\n              </a></sup><span>; </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=PHOSP-COVID+Study+Collaborative+Group%5BCorporate+Author%5D\">PHOSP-COVID Study Collaborative Group</a><span>; </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Sproul+D&amp;cauthor_id=41152617\">Duncan Sproul</a><sup><span> </span><a target=\"_blank\" title=\"MRC Human Genetics Unit and CRUK Edinburgh Centre, MRC IGC, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-22\">\n                22\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Baillie+JK&amp;cauthor_id=41152617\">J Kenneth Baillie</a><sup><span> </span><a target=\"_blank\" title=\"The Roslin Institute, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-23\">\n                23\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Thompson+AAR&amp;cauthor_id=41152617\">Alfred A R Thompson</a><sup><span> </span><a target=\"_blank\" title=\"Division of Clinical Medicine, University of Sheffield, Sheffield, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-11\">\n                11\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Mole+DR&amp;cauthor_id=41152617\">David R Mole</a><sup><span> </span><a target=\"_blank\" title=\"NDM Research Building, Nuffield Department of Medicine, University of Oxford, Oxford, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-9\">\n                9\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=von+Kriegsheim+A&amp;cauthor_id=41152617\">Alex von Kriegsheim</a><sup><span> </span><a target=\"_blank\" title=\"CRUK Scotland Centre, IGC, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-6\">\n                6\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Whyte+MKB&amp;cauthor_id=41152617\">Moira K B Whyte</a><sup><span> </span><a target=\"_blank\" title=\"Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-1\">\n                1\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Mhalanga+MM&amp;cauthor_id=41152617\">Musa M Mhalanga</a><sup><span> </span><a target=\"_blank\" title=\"Department of Internal Medicine and Radboud Center for Infectious Diseases, Radboud University Medical Center, Nijmegen, the Netherlands.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-3\">\n                3\n              </a><span> </span><a target=\"_blank\" title=\"Department of Cell Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, the Netherlands.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-4\">\n                4\n              </a><span> </span><a target=\"_blank\" title=\"Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-5\">\n                5\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Nathan+JA&amp;cauthor_id=41152617\">James A Nathan</a><sup><span> </span><a target=\"_blank\" title=\"Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Department of Medicine, University of Cambridge, Cambridge, UK.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-2\">\n                2\n              </a></sup><span>, </span></span><span><a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=Walmsley+SR&amp;cauthor_id=41152617\">Sarah R Walmsley</a><sup><span> </span><a target=\"_blank\" title=\"Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK. sarah.walmsley@ed.ac.uk.\" href=\"https://pubmed.ncbi.nlm.nih.gov/41152617/?fc=None&amp;ff=20251105032325&amp;v=2.18.0.post22+67771e2#full-view-affiliation-24\">\n                24\n              </a></sup></span>\n  </p></div>\n          <p>\n    Affiliations\n</p>\n    <ul>\n        <li>\n          <span>\n  <span>\n      PMID:\n  </span>\n    <strong>41152617</strong>\n</span>\n        </li>\n        <li>\n          <span>\n  <span>\n      PMCID:\n  </span>\n    <a target=\"_blank\" href=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC12571872/\">\n      PMC12571872\n    </a>\n</span>\n        </li>\n        <li>\n          <span>\n  <span>\n      DOI:\n  </span>\n    <a target=\"_blank\" href=\"https://doi.org/10.1038/s41590-025-02301-9\">\n      10.1038/s41590-025-02301-9\n    </a>\n</span>\n        </li>\n    </ul>\n        <p>\n  Item in Clipboard\n</p>\n      </div>\n      <div>\n<h2>\n  Hypoxia induces histone clipping and H3K4me3 loss in neutrophil progenitors resulting in long-term impairment of neutrophil immunity\n</h2>\n<p><span>\n        <span><span>Manuel A Sanchez-Garcia</span><span> et al.</span></span>\n  </span>\n      <span>\n        Nat Immunol<span>.</span>\n      </span>\n        <span>\n          <span>2025 Nov</span><span>.</span>\n        </span>\n</p>\n      </div>\n  <div>\n      <h2>\n        Abstract\n      </h2>\n            <p>\n      The long-term impact of systemic hypoxia resulting from acute respiratory distress syndrome (ARDS) on the function of short-lived innate immune cells is unclear. We show that patients 3-6 months after recovering from ARDS have persistently impaired circulating neutrophil effector functions and an increased susceptibility to secondary infections. These defects are linked to a widespread loss of the activating histone mark H3K4me3 in genes that are crucial for neutrophil activities. By studying healthy volunteers exposed to altitude-induced hypoxemia, we demonstrate that oxygen deprivation alone causes this long-term neutrophil reprogramming. Mechanistically, mouse models of systemic hypoxia reveal that persistent loss of H3K4me3 originates in proNeu and preNeu progenitors within the bone marrow and is linked to N-terminal histone 3 clipping, which removes the lysine residue for methylation. Thus, we present new evidence that systemic hypoxia initiates a sustained maladaptive reprogramming of neutrophil immunity by triggering histone 3 clipping and H3K4me3 loss in neutrophil progenitors.\n    </p>\n  </div>\n  <p>\n    © 2025. The Author(s).\n  </p>\n  <p>\n  <a href=\"https://pubmed.ncbi.nlm.nih.gov/disclaimer/\" target=\"_blank\">PubMed Disclaimer</a>\n</p>\n  <div>\n    <h2>\n      Conflict of interest statement\n    </h2>\n    <p>Competing interests: The authors declare no competing interests.</p>\n  </div>\n      <div>\n        <h2>\n          Figures\n        </h2>\n        <div>\n            <figure>\n              <a target=\"_blank\" href=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/d6a183735e7e/41590_2025_2301_Fig1_HTML.jpg\">\n                <img src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/6ee1438733ad/41590_2025_2301_Fig1_HTML.gif\" alt=\"Fig. 1\" />\n              </a>\n                <figcaption>\n    <strong>\n      Fig. 1. ARDS induces long-term alterations of neutrophil phenotypes and functions.\n    </strong>\n    <div><p><b>a</b>–<b>i</b>, Phenotypic and functional analysis of circulating neutrophils collected from healthy controls and survivors of ARDS 3–6 months post-hospital admission. <b>a</b>, Schematic representation of the analyses performed. Human silhouette adapted from Wikipedia commons (</p>https://commons.wikimedia.org/wiki/File:Man_shadow_-_upper.png<p>); lungs, neutrophils and blood tube adapted from Servier license under </p>CC-BY 3.0 Unported<p>. <b>b</b>, Circulating neutrophil counts obtained by flow cytometry (<i>n</i> = 19 healthy control and <i>n</i> = 26 ARDS survivor). <b>c</b>,<b>d</b>, Surface expression of the neutrophil activation markers CD66b and CD62L measured by flow cytometry (<i>n</i> = 15 healthy control and <i>n</i> = 14 ARDS survivor (<b>c</b>), <i>n</i> = 10 healthy control and <i>n</i> = 13 ARDS survivor (<b>d</b>)). <b>e</b>, Metabolite abundance of pyruvate, lactate and acetyl-CoA obtained by LC–MS analysis (<i>n</i> = 5 for both experimental groups). <b>f</b>, Proteomic analysis by LC–MS showing abundance of cytoskeletal (</p>GO:0005856<p>) and azurophilic granule cargo proteins (</p>GO:0035578<p>) (<i>n</i> = 8 for both experimental groups). <b>g</b>, Ex vivo quantification of α-1-antitrypsin from neutrophil culture supernatants performed by ELISA (<i>n</i> = 4 for both experimental groups, two technical replicates per sample). <b>h</b>, Ex vivo neutrophil survival in response to LPS stimulation after 20 h of culture evaluated by microscopy analysis (<i>n</i> = 7 for both experimental groups, two technical replicates per sample). <b>i</b>, Phagocytic capacity of opsonized <i>S. aureus</i> SH1000 measured by flow cytometry as a percentage of the total neutrophil population analyzed (<i>n</i> = 4 for both experimental groups, two technical replicates per sample). <b>j</b>, Infections recorded in ARDS survivors, with their infection etiologies expressed as proportion or as cumulative positive microbiology results over the course of 6 months post-ARDS. <b>b</b>–<b>i</b>, Data show mean ± s.d., with each value representing an individual. Significant <i>P</i> values depicted (for <i>P</i> &lt; 0.05) and obtained by Shapiro–Wilk normality test followed by a two-tailed <i>t</i>-test (<b>b</b>–<b>i</b>) or two-tailed Mann–Whitney <i>U</i>-test (<b>c</b>, cytoskeleton (<b>f</b>)). FC, fold change; gMFI, geometric mean fluorescence intensity; a.u., arbitrary units. Source data</p></div>\n                </figcaption>\n            </figure>\n            <figure>\n              <a target=\"_blank\" href=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/695ccdd29a67/41590_2025_2301_Fig2_HTML.jpg\">\n                <img src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/f3bdd2cbb14a/41590_2025_2301_Fig2_HTML.gif\" alt=\"Fig. 2\" />\n              </a>\n                <figcaption>\n    <strong>\n      Fig. 2. Circulating neutrophils during ARDS show metabolic rewiring that can influence epigenetic reactions.\n    </strong>\n    <div><p><b>a</b>, Diagram of the studies performed in circulating neutrophils from patients during the acute phase of ARDS and healthy control samples. Human silhouette adapted from Wikimedia commons (</p>https://commons.wikimedia.org/wiki/File:Man_shadow_-_upper.png<p>); lungs, neutrophils and blood tube adapted from </p>Servier<p> license under </p>CC-BY 3.0 Unported<p>. <b>b</b>, Circulating white cell and neutrophil counts during the acute phase of ARDS obtained from ARDS survivors in Fig. 1 (<i>n</i> = 43). <b>c</b>, Lowest partial pressures of oxygen (<i>P</i>aO<sub>2</sub>) and highest fraction of inspired oxygen (<i>F</i>iO<sub>2</sub>) from clinical arterial blood samples during the acute phase of ARDS obtained from ARDS survivors in Fig. 1 (shadowed area depicts normal <i>P</i>aO<sub>2</sub> range and dashed line reflects 21% O<sub>2</sub>) (<i>n</i> = 24). <b>d</b>,<b>e</b>, Abundance of proteins and metabolites measured in circulating neutrophils from healthy control and acute ARDS patients by LC–MS analysis obtained from previous datasets. <b>d</b>, Schema of relevant steps involved in fatty acid transport and oxidation, with dashed lines summarizing multiple enzymatic steps alongside quantification of the abundance of proteins and metabolites (<i>n</i> = 4 healthy control and <i>n</i> = 11 ARDS for ACSL1, CPT1A, SLC25A20, ACAA2 and HADH, <i>n</i> = 5 healthy control and <i>n</i> = 6 ARDS for Acetyl-CoA). <b>e</b>, Schema of proteins and metabolites linked to one-carbon metabolism pathway alongside quantification of their abundance (<i>n</i> = 4 healthy control and <i>n</i> = 11 ARDS for SHMT2 and MAT2A, <i>n</i> = 5 healthy control and <i>n</i> = 15 ARDS for methionine). Data as mean ± s.d., with each value representing an individual. Significant <i>P</i> values depicted (for <i>P</i> &lt; 0.05) and obtained by Shapiro–Wilk normality test followed by two-tailed <i>t</i>-test (ACSL1, Acetyl-CoA, SHMT1, MAT2A and methionine (<b>d</b>,<b>e</b>)) or two-tailed Mann–Whitney <i>U</i>-test (CPT1A, SLC25A20, ACAA2 and HADH (<b>d</b>,<b>e</b>)). Source data</p></div>\n                </figcaption>\n            </figure>\n            <figure>\n              <a target=\"_blank\" href=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/260bf90084ad/41590_2025_2301_Fig3_HTML.jpg\">\n                <img src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/b769f51f279c/41590_2025_2301_Fig3_HTML.gif\" alt=\"Fig. 3\" />\n              </a>\n                <figcaption>\n    <strong>\n      Fig. 3. Genes involved in core functions in circulating neutrophils express diminished H3K4me3 levels months following ARDS.\n    </strong>\n    <p><b>a</b>–<b>g</b>, Chromatin immunoprecipitation sequencing analysis of genomic regions associated with H3K4me3 in healthy donors’ blood neutrophils compared to those from patients surviving ARDS 3–6 months post-hospital admission depicting corticosteroid treatment. <b>a</b>, Principal-component analysis of the three sample groups with each dot representing an individual. <b>b</b>, Metagene H3K4me3 profiles 3-kb upstream from the transcription start site (TSS) and downstream from the transcription end site (TES) of the three sample groups, with the s.e.m. shown as shading around the mean curve. Data are expressed as log<sub>2</sub>FC versus input control levels. <b>c</b>, Differential peaks obtained through the R package Diffbind when comparing the three sample groups. <b>d</b>, GO analysis by Reactome pathway enrichment in the ARDS survivors’ groups versus healthy controls. <b>e</b>–<b>g</b>, Individual gene tracks for genes involved in granule proteins and maturation (<b>e</b>), calcium signaling (<b>f</b>) and inflammatory responses (<b>g</b>) depicting H3K4me3 profiles for healthy controls and ARDS survivors. The numbers of biological replicates were healthy controls (<i>n</i> = 3), ARDS survivors who did not receive corticosteroid treatment (<i>n</i> = 3) and corticosteroid-treated ARDS survivors (<i>n</i> = 4). The false discovery rate was applied to generate <b>d</b>. Details on normalization and quality control analysis in Extended Data Fig. 3 and Methods.</p>\n                </figcaption>\n            </figure>\n            <figure>\n              <a target=\"_blank\" href=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/477085281b8a/41590_2025_2301_Fig4_HTML.jpg\">\n                <img src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/16a51ae3116a/41590_2025_2301_Fig4_HTML.gif\" alt=\"Fig. 4\" />\n              </a>\n                <figcaption>\n    <strong>\n      Fig. 4. Long-term neutrophil changes in response to ARDS are mirrored by altitude-induced hypoxemia.\n    </strong>\n    <div><p><b>a</b>–<b>j</b>, Paired longitudinal analysis of blood neutrophils from volunteers at baseline and 3–4 months after a 7-day period of altitude-induced hypoxemia (post-altitude). <b>a</b>, Diagram of the analyses performed with the altitude-induced hypoxemia human cohort. Hiker adapted from Wikimedia commons (</p>https://commons.wikimedia.org/wiki/File:Big_guy_637%27s_hiking_icon.svg<p>); mountain adapted from </p>Unsplash<p>; neutrophils and blood tube adapted from </p>Servier<p> under license </p>CC-BY 3.0<p> Unported. <b>b</b>, Oxygen saturation levels at baseline, at day 5 of an acclimatization period at 3,640 m of altitude, at day 7 after ascending to 4,775 m of altitude, and post-altitude (<i>n</i> = 18 for the different time points, exact <i>P</i> value = 0.4 × 10<sup>−7</sup> for depicted <i>P</i> &lt; 0.001). SpO<sub>2</sub>, peripheral oxygen saturation. <b>c</b>, Circulating neutrophil counts obtained by flow cytometry (<i>n</i> = 20 both time points). <b>c</b>, Surface expression of the neutrophil activation markers CD66b and CD62L measured by flow cytometry (<i>n</i> = 20 for both time points, exact <i>P</i> value = 0.2 × 10<sup>−5</sup> for CD66b and <i>P</i> value = 0.0002 for CD62L). <b>e</b>, Proteomic analysis by LC–MS showing abundance of cytoskeletal (</p>GO:0005856<p>) and total granule cargo proteins (</p>GO:0035578<p>, </p>GO:0035580<p>, and </p>GO:1904724<p>) (<i>n</i> = 10 for both time points). <b>f</b>, Ex vivo quantification of myeloperoxidase (MPO) from neutrophil culture supernatants performed by ELISA (<i>n</i> = 9 for both time points, two technical replicates per sample). <b>g</b>, Phagocytic capacity of opsonized <i>S. aureus</i> SH1000 measured by flow cytometry (<i>n</i> = 14 for both time points, two technical replicates per sample). <b>h</b>–<b>j</b>, Analysis of H3K4me3 levels in genes involved in granule proteins and maturation (<b>h</b>) (<i>n</i> = 8 for both time points, two technical replicates per sample), calcium signaling (<b>i</b>) (<i>n</i> = 14 for both time points, two technical replicates per sample) and inflammatory responses (<b>j</b>) (<i>n</i> = 7 for <i>IFNAR2</i> and <i>n</i> = 8 for <i>CXCR2</i> for both time points, two technical replicates per sample) by ChIP–qPCR expressed as % of input. Each set of values linked through a line represents an individual. Significant <i>P</i> values depicted (for <i>P</i> &lt; 0.05) and obtained by Shapiro–Wilk normality test followed by Friedman test (<b>b</b>), two-tailed paired <i>t</i>-test (<b>c</b>, CD62L (<b>d</b>), cytoskeleton (<b>e</b>), <b>h</b>,<b>i</b>, <i>CXCR2</i> (<b>j</b>)) or two-tailed Wilcoxon test (CD66b (<b>d</b>), total granules cargo (<b>e</b>), <b>f</b>,<b>g</b>, <i>IFNAR2</i> (<b>j</b>)). Source data</p></div>\n                </figcaption>\n            </figure>\n            <figure>\n              <a target=\"_blank\" href=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/282332aadc40/41590_2025_2301_Fig5_HTML.jpg\">\n                <img src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/58741c6a19a0/41590_2025_2301_Fig5_HTML.gif\" alt=\"Fig. 5\" />\n              </a>\n                <figcaption>\n    <strong>\n      Fig. 5. Systemic hypoxia compromises bactericidal capacity and produces H3K4me3 loss in neutrophil progenitors.\n    </strong>\n    <div><p><b>a</b>, Schema of the murine infection model used: mice were subjected to 10% O<sub>2</sub> for 1 week followed by a 5-week reoxygenation period before subcutaneous infection with <i>S. aureus</i> SH1000 (Hpx + ReNmx). Normoxia counterparts (Nmx) were used as experimental controls to evaluate infection outcomes 48 h post-challenge. <b>b</b>,<b>c</b>, Representative abscess (black arrowhead) images 24 h following infection, including abscess size quantification (<b>b</b>) and bacterial burden (c.f.u.) (<b>c</b>) 48 h post-infection (<i>n</i> = 9 for both experimental groups). Scale bar, 1 cm. <b>d</b>, Schema of the murine lung injury model used in <b>e</b>,<b>g</b>: mice were nebulized (HpxLPS + ReNmx) or not (Hpx + ReNmx) with LPS and subjected to 10% O<sub>2</sub> for 1 week followed by a 5-week reoxygenation period, when bone-marrow cells were collected. Normoxia counterparts (Nmx) were used as experimental controls. <b>e</b>, H3K4me3 levels normalized by total histone 4 content (H4) obtained by immunoblot in mature neutrophils isolated by FACS from the mouse model in <b>d</b> (<i>n</i> = 7 Nmx and <i>n</i> = 3 HpxLPS + ReNmx). log<sub>2</sub>FC from average Nmx is depicted. <b>f</b>, Simplified representation of the neutrophil hematopoietic lineage, including hematopoietic stem cells (HSCs), GMPs and the neutrophil-committed progenitors proNeu1, proNeu2 and preNeu. <b>g</b>, Single gene tracks reflecting H3K4me3 occupancy obtained by Cut&amp;Run sequencing analysis in GMPs isolated from the mouse model in <b>d</b>. <b>h</b>–<b>j</b>, Levels of H3K4me3 as a ratio of total histone 3 (H3) in bone-marrow proNeu1 (<b>h</b>), proNeu2 (<b>i</b>) and preNeu (<b>j</b>) from mice subjected to 10% O<sub>2</sub> for 1 week followed by a 3-month reoxygenation period (Hpx + ReNmx) compared to normoxia control mice (Nmx) obtained by flow cytometry (<i>n</i> = 4 Nmx and <i>n</i> = 3 Hpx + ReNmx). log<sub>2</sub>FC from average Nmx is depicted. Each data point represents a mouse. Data show mean ± s.d. Significant <i>P</i> values are depicted (for <i>P</i> &lt; 0.05) and were obtained by a Shapiro–Wilk normality test followed by two-tailed <i>t</i>-test (<b>c</b>\n<b>e</b>,<b>h</b>–<b>j</b>) or two-tailed Mann–Whitney <i>U</i>-test (<b>b</b>). Mouse in panel <b>a</b>,<b>d</b> adapted from </p>Servier<p> under license </p>CC-BY 3.0 Unported<p>; femur in panel <b>d</b> and cells in panels <b>e</b>–<b>j</b> adapted from Servier (</p>https://smart.servier.com/smart_image<p>) under license </p>CC-BY 4.0<p>. Source data</p></div>\n                </figcaption>\n            </figure>\n            <figure>\n              <a target=\"_blank\" href=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/018a4c8b482a/41590_2025_2301_Fig6_HTML.jpg\">\n                <img src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/a787002e7eba/41590_2025_2301_Fig6_HTML.gif\" alt=\"Fig. 6\" />\n              </a>\n                <figcaption>\n    <strong>\n      Fig. 6. Hypoxia-induced loss of H3K4me3 and impaired host defense are associated with H3 tail clipping and can be partially restored by BCG vaccination.\n    </strong>\n    <div><p><b>a</b>, Schema of the acute systemic hypoxia murine model used for histone studies in <b>b</b>–<b>d</b>: mice were nebulized (HpxLPS) or not (Hpx) with LPS and subjected to 10% O<sub>2</sub> for 1 week, with normoxia counterparts (Nmx) used as experimental controls. Bone-marrow preNeu were isolated by FACS, lysed and submitted to chymotrypsin digestion. LC–MS was used to identify histone peptides. <b>b</b>, Total number of histone peptides identified. <b>c</b>, Total intensity for the peptides corresponding to H3. <b>d</b>, Abundance of N-terminal H3 peptides normalized by total H3 at different peptide start sites within the H3 protein sequence in <b>a</b> (<i>n</i> = 4 for all the experimental groups, two technical replicates per condition). Highlighted region in red depicts the fraction containing the trimethylation site lost in hypoxic conditions. <b>e</b>, Schema of the murine infection model used: mice were exposed to hypoxic lung injury with LPS nebulization followed by 1 week of hypoxia (10% O<sub>2</sub>, HpxLPS). Following return to normoxia (ReNmx), mice were vaccinated with BCG (HpxLPS + ReNmx BCG) or PBS control (HpxLPS + ReNmx vehicle) on either day 8 (circle) or day 21 (triangle) and, after 5 weeks recovery, challenged with a subcutaneous infection of <i>S. aureus</i>. <b>f</b>, Abscess c.f.u. counts 48 h post-infection (<i>n</i> = 8 HpxLPx + ReNmx vehicle and <i>n</i> = 17 HpxLPS + ReNmx BCG). <b>g</b>, Levels of H3K4me3 as a ratio of total histone 3 (H3) in circulating neutrophils obtained by flow cytometry (<i>n</i> = 3 for both experimental groups). log<sub>2</sub>FC from average HpxLPS + ReNmx vehicle is depicted. Each data point represents one mouse (<b>b</b>,<b>c</b>,<b>f</b>,<b>g</b>) or <i>n</i> = 4 mice per experimental group (<b>d</b>). Data show mean ± s.d. <i>P</i> values are depicted and were obtained by a Shapiro–Wilk normality test followed by a two-tailed <i>t</i>-test (<b>f</b>,<b>g</b>) or two-way analysis of variance (<b>b</b>–<b>d</b>). Mouse icons in panel <b>a</b>,<b>e</b> adapted from </p>Servier<p> under license </p>CC-BY 3.0 Unported<p>; femur in panel <b>a</b> adapted from Servier (</p>https://smart.servier.com/smart_image<p>) under license </p>CC-BY 4.0<p>; plate and mass spectrometer from panel <b>a</b> reproduced from </p>Servier<p> under licenses </p>CC1 1.0 Universal<p> and </p>CC-BY 4.0<p> Unported, respectively. Source data</p></div>\n                </figcaption>\n            </figure>\n            <figure>\n              <a target=\"_blank\" href=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/1007b351288d/41590_2025_2301_Fig7_HTML.jpg\">\n                <img src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/6bfd5d5188e3/41590_2025_2301_Fig7_HTML.gif\" alt=\"Fig. 7\" />\n              </a>\n                <figcaption>\n    <strong>\n      Fig. 7. Summary diagram.\n    </strong>\n    <div><p>In response to hypoxia, clipping of the N-terminal region of H3 in neutrophil-committed progenitors leads to loss of the H3K4 lysine trimethylation site. This widespread reduction in H3K4me3 is transmitted to differentiated neutrophils and perpetuated due to the mitotic capacity of neutrophil precursors. As a result, newly formed neutrophils present alterations in their phenotype and effector function in the long term with consequences for infection outcomes. Human silhouette adapted from Wikimedia commons (</p>https://commons.wikimedia.org/wiki/File:Man_shadow_-_upper.png<p>); femur, neutrophils and stem cells adapted from Servier (</p>https://smart.servier.com/smart_image<p>) under license </p>CC-BY 4.0<p>; neutrophils and DNA adapted from </p>Servier<p> under license </p>CC-BY 3.0 Unported<p>; nueclosome adapted from </p>Servier<p> under license </p>CC0 1.0 Universal<p>.</p></div>\n                </figcaption>\n            </figure>\n            <figure>\n              <a target=\"_blank\" href=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/06d0fd8cfb00/41590_2025_2301_Fig8_ESM.jpg\">\n                <img src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/bf4435d96c13/41590_2025_2301_Fig8_ESM.gif\" alt=\"Extended Data Fig. 1\" />\n              </a>\n                <figcaption>\n    <strong>\n      Extended Data Fig. 1. Equivalent metabolic intermediaries and core molecular processes are observed in neutrophils months after ARDS.\n    </strong>\n    <div><p><b>a</b>–<b>h</b>, Maturity, and metabolic and proteomic liquid chromatography-mass spectrometry analysis of circulating neutrophils harvested from healthy controls and acute respiratory distress syndrome (ARDS) survivors 3–6 months post-hospital admission. <b>a</b>. Mature (circle) and immature (triangle) blood neutrophil counts obtained by flow cytometry by analyzing CD16 surface expression (n = 4 healthy control and n = 9 ARDS survivor). <b>b</b>, Abundance of TCA metabolites. <b>c</b>, Abundance of metabolites related to one-carbon metabolism pathways. <b>d</b>, Energy status expressed as the ratio of ATP/ADP and AMP abundance (n = 5 for both experimental groups). <b>e</b>, Number of proteins identified by proteomic analysis. <b>f</b>, Principal-component analysis of proteomic data. <b>g</b>, Proteomic survey of the core cellular elements mitochondria (</p>GO:0005739<p>), nuclear envelope (</p>GO:0005635<p>), ribosome (Kyoto Encyclopedia of Genes and Genomes annotation 03010) and eukaryotic initiation factor 4 F. <b>h</b>, Total granule cargo proteins (</p>GO:0035578<p>, </p>GO:0035580<p>, and </p>GO:1904724<p>) (n = 8 for both sample groups). Data as mean ± s.d. (except <b>f</b>). Each value represents an individual. Significant p values depicted (for p &lt; 0.05) and obtained by Shapiro–Wilk normality test followed by 2-way ANOVA test (<b>a</b>), two-tailed t-test (<b>b</b>–<b>e</b>, <b>g</b>) or two-tailed Mann–Whitney test (<b>h</b>). Source data</p></div>\n                </figcaption>\n            </figure>\n            <figure>\n              <a target=\"_blank\" href=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/66166ced3733/41590_2025_2301_Fig9_ESM.jpg\">\n                <img src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/1e9ce515d741/41590_2025_2301_Fig9_ESM.gif\" alt=\"Extended Data Fig. 2\" />\n              </a>\n                <figcaption>\n    <strong>\n      Extended Data Fig. 2. Circulating neutrophils from ARDS patients during the acute phase of the syndrome present changes in the epigenetic machinery.\n    </strong>\n    <p><b>a</b>, <b>b</b>, Abundance of proteins measured in circulating neutrophils from healthy control and acute respiratory distress syndrome (ARDS) patients by chromatography-mass spectrometry analysis obtained from previous datasets (n = 4 healthy control and n = 11 ARDS). Each value represents an individual. Data as mean ± s.d. Significant p values depicted (for p &lt; 0.05) and obtained by Shapiro–Wilk normality test followed by two-tailed t-test (MTA2, RBBP4, ASH2L, RBBP5 (<b>a</b>, <b>b</b>)) or two-tailed Mann–Whitney test (HDAC2 (<b>a</b>)). Source data</p>\n                </figcaption>\n            </figure>\n            <figure>\n              <a target=\"_blank\" href=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/d47885c23aff/41590_2025_2301_Fig10_ESM.jpg\">\n                <img src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/8e2128b13cd4/41590_2025_2301_Fig10_ESM.gif\" alt=\"Extended Data Fig. 3\" />\n              </a>\n                <figcaption>\n    <strong>\n      Extended Data Fig. 3. H3K4me3 peaks are enriched at the transcription start site and show preserved levels in certain genomic regions.\n    </strong>\n    <p><b>a</b>, <b>b</b>, Tapestation profiles (<b>a</b>) of the fragment size distribution (<b>b</b>) detected in the input control samples from the healthy control group and acute respiratory distress syndrome (ARDS) survivor subgroups according to corticosteroid treatment. <b>c</b>, Representation of H3K4me3 levels when distributing 10000 bins around transcription start sites (TSS, left) or randomly across the genome (right) in the clinical groups included in (<b>a</b>). <b>d</b>, Individual gene tracks for unaltered H3K4me3 profiles in the sample groups included in (<b>a</b>). The number of biological replicates was healthy control (n = 3), ARDS survivor who did not receive corticosteroid treatment (n = 3), and corticosteroid-treated ARDS survivor (n = 4). Details on normalization and QC analysis in methods section.</p>\n                </figcaption>\n            </figure>\n            <figure>\n              <a target=\"_blank\" href=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/3a08e2493883/41590_2025_2301_Fig11_ESM.jpg\">\n                <img src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/5a2c9b4617a6/41590_2025_2301_Fig11_ESM.gif\" alt=\"Extended Data Fig. 4\" />\n              </a>\n                <figcaption>\n    <strong>\n      Extended Data Fig. 4. Proteomic study of blood neutrophils at baseline and after altitude-induced hypoxemia reveals preservation of core cellular processes.\n    </strong>\n    <div><p><b>a</b>–<b>c</b>, Liquid chromatography-mass spectrometry analysis of the proteome of circulating neutrophils from healthy volunteers at baseline and 3–4 months after a 7-day period of altitude-induced hypoxemia (post-altitude) (n = 10 for both time points). <b>a</b>, Number of proteins identified. <b>b</b>, Principal-component analysis. <b>c</b>, Proteomic survey of the core cellular elements mitochondria (</p>GO:0005739<p>), nuclear envelope (</p>GO:0005635<p>), ribosome (Kyoto Encyclopedia of Genes and Genomes annotation 03010) and eukaryotic initiation factor 4 F. Each set of values linked through a line represents an individual. Significant p values depicted (for p &lt; 0.05) and obtained by Shapiro–Wilk normality test followed by two-tailed paired t-test (<b>a</b>, <b>c</b>) or two-tailed Wilcoxon test (mitochondria (<b>c</b>)). Source data</p></div>\n                </figcaption>\n            </figure>\n            <figure>\n              <a target=\"_blank\" href=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/71ed76e8bd97/41590_2025_2301_Fig12_ESM.jpg\">\n                <img src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/4c0291ba1773/41590_2025_2301_Fig12_ESM.gif\" alt=\"Extended Data Fig. 5\" />\n              </a>\n                <figcaption>\n    <strong>\n      Extended Data Fig. 5. Exposure to hypoxia does not affect the frequencies of circulating neutrophils upon infection, progenitor abundance or N-terminal H2B clipping in mice.\n    </strong>\n    <p><b>a</b>, Circulating neutrophil abundance obtained by flow cytometry in mice exposed to 10 % O<sub>2</sub> for a week followed by a 5-week reoxygenation period prior to subcutaneous infection with <i>S. aureus</i> SH1000 (Hpx + ReNmx). Normoxia counterparts (Nmx) were used as experimental controls. Data expressed as a percentage from CD45<sup>+</sup> cells 48 h post-challenge (n = 4 Nmx and n = 5 Hpx + ReNmx). <b>b</b>, Granulocyte monocyte progenitor (GMP) and Common myeloid progenitor (CMP) abundance quantification by flow cytometry in the bone marrow of mice nebulized (HpxLPS + ReNmx) with LPS or not (Hpx + ReNmx) and exposed to 10 % O<sub>2</sub> for a week followed by a 5-week reoxygenation period. Normoxia counterparts (Nmx) were used as experimental controls (n = 3 for all experimental conditions). <b>c</b>–<b>e</b>, Quantification of bone marrow proNeu1, proNeu2 and preNeu from mice subjected to 10 % O<sub>2</sub> for a week followed by a 3-month reoxygenation period (Hpx + ReNmx) compared to normoxia control mice (Nmx) obtained by flow cytometry as a proportion of Alive/Lin- cells (n = 4 Nmx and n = 3 Hpx + ReNmx). <b>f</b>, <b>g</b>, Mice were nebulized (HpxLPS) or not (Hpx) with LPS and subjected to 10 % O<sub>2</sub> for a week, with normoxia counterparts (Nmx) used as experimental controls. Bone marrow preNeu were harvested and lysed followed by chymotrypsin digestion. Liquid chromatography-mass spectrometry (LC–MS) was used to identify histone peptides. <b>f</b>, Total intensity for the peptides corresponding to histone 2 (H2). <b>g</b>, Abundance of N-terminal histone H2B peptide corresponding to amino acids 5-20 in the protein sequence (n = 4 for all experimental conditions). Data as mean ± s.d. Each value represents a mouse, except (<b>b</b>), with 4 mice pooled to obtain each data point. Significant p values depicted (for p &lt; 0.05) and obtained by Shapiro-Wilk normality test followed by two-tailed t-test (<b>a</b>, <b>c</b>, <b>e</b>), 1-way ANOVA (<b>b</b>), two-tailed Mann–Whitney test (<b>d</b>), or 2-way ANOVA (<b>f</b>, <b>g</b>). Source data</p>\n                </figcaption>\n            </figure>\n            <figure>\n              <a target=\"_blank\" href=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/28c00e422f70/41590_2025_2301_Fig13_ESM.jpg\">\n                <img src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/5d3d4ec8dc93/41590_2025_2301_Fig13_ESM.gif\" alt=\"Extended Data Fig. 6\" />\n              </a>\n                <figcaption>\n    <strong>\n      Extended Data Fig. 6. Use of normalized intensity as opposed to extrapolated copy number.\n    </strong>\n    <p><b>a</b>, Total protein content obtained after applying the proteomic ruler method to calculate protein copy number and total intensity from liquid chromatography-mass spectrometry proteomic data from blood neutrophils in healthy donors compared to acute respiratory distress syndrome (ARDS) survivors 3–6 months post-hospital admission (n = 8 for both experimental groups). Data as mean ± s.d., with each value representing an individual. Significant p values depicted (for p &lt; 0.05) and obtained by Shapiro-Wilk normality test followed by two-tailed t-test. Source data</p>\n                </figcaption>\n            </figure>\n            <figure>\n              <a target=\"_blank\" href=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/1bc0256dd8c6/41590_2025_2301_Fig14_ESM.jpg\">\n                <img src=\"https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5db/12571872/aea49f59093d/41590_2025_2301_Fig14_ESM.gif\" alt=\"Extended Data Fig. 7\" />\n              </a>\n                <figcaption>\n    <strong>\n      Extended Data Fig. 7. Representative gating strategy.\n    </strong>\n    <p><b>a</b>–<b>c</b>, Pseudocolor plots containing gates depicting the sequential gating strategy followed for human blood neutrophil phenotypic and maturation experiments (<b>a</b>), mouse bone marrow granulocyte monocyte progenitor (GMP) and common myeloid progenitor (CMP) FACS sorting (<b>b</b>), and mouse bone marrow survey of proNeu1, proNeu2 and preNeu neutrophil-committed progenitors (<b>c</b>) for identification by flow cytometry or FACS. Percentages refer to Alive (<b>a</b>) or Alive/Lin- (<b>b</b>, <b>c</b>) gates.</p>\n                </figcaption>\n            </figure>\n        </div>\n      </div>\n  <div>\n    <h2>\n      References\n    </h2>\n    <div>\n      <ol>\n  <li>\n    <ol>\n        <li>\n            Flick, M. R., Perel, A. &amp; Staub, N. C. Leukocytes are required for increased lung microvascular permeability after microembolization in sheep. <i>Circ. Res.</i><b>48</b>, 344–351 (1981).\n                  -\n                  <a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/7460207/\">\n                    PubMed\n                  </a>\n        </li>\n    </ol>\n  </li>\n  <li>\n    <ol>\n        <li>\n            Grommes, J. &amp; Soehnlein, O. Contribution of neutrophils to acute lung injury. <i>Mol. Med.</i><b>17</b>, 293–307 (2011).\n                  -\n                  <a target=\"_blank\" href=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3060975/\">\n                    PMC\n                  </a>\n                  -\n                  <a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/21046059/\">\n                    PubMed\n                  </a>\n        </li>\n    </ol>\n  </li>\n  <li>\n    <ol>\n        <li>\n            Bellani, G. et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. <i>JAMA</i><b>315</b>, 788–800 (2016).\n                  -\n                  <a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/26903337/\">\n                    PubMed\n                  </a>\n        </li>\n    </ol>\n  </li>\n  <li>\n    <ol>\n        <li>\n            Zemans, R. L. &amp; Matthay, M. A. What drives neutrophils to the alveoli in ARDS? <i>Thorax</i><b>72</b>, 1–3 (2017).\n        </li>\n    </ol>\n  </li>\n  <li>\n    <ol>\n        <li>\n            Schulte-Schrepping, J. et al. Severe COVID-19 is marked by a dysregulated myeloid cell compartment. <i>Cell</i><b>182</b>, 1419–1440.e23 (2020).\n                  -\n                  <a target=\"_blank\" href=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC7405822/\">\n                    PMC\n                  </a>\n                  -\n                  <a target=\"_blank\" href=\"https://pubmed.ncbi.nlm.nih.gov/32810438/\">\n                    PubMed\n                  </a>\n        </li>\n    </ol>\n  </li>\n      </ol>\n</div>\n  </div>\n    <div>\n      <h2>\n        MeSH terms\n      </h2>\n      <ul><li></li><li></li><li></li><li></li><li></li><li></li><li></li><li></li><li></li><li></li><li></li><li></li><li></li><li></li><li></li><li></li><li></li><li></li><li></li></ul>\n    </div>\n    <div>\n      <h2>\n        Substances\n      </h2>\n      <ul><li></li><li></li></ul>\n    </div>\n    <div>\n      <h2>\n        Grants and funding\n      </h2>\n      <div><ul><li><a target=\"_blank\" title=\"All articles for grant 224637/WT_/Wellcome Trust/United Kingdom\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=224637%2FWT_%2FWellcome+Trust%2FUnited+Kingdom%5BGrants+and+Funding%5D&amp;sort=date&amp;sort_order=desc\">\n          224637/WT_/Wellcome Trust/United Kingdom\n        </a></li><li><a target=\"_blank\" title=\"All articles for grant FS/18/13/33281/British Heart Foundation (BHF)\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=FS%2F18%2F13%2F33281%2FBritish+Heart+Foundation+%28BHF%29%5BGrants+and+Funding%5D&amp;sort=date&amp;sort_order=desc\">\n          FS/18/13/33281/British Heart Foundation (BHF)\n        </a></li><li><a target=\"_blank\" title=\"All articles for grant 110086/WT_/Wellcome Trust/United Kingdom\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=110086%2FWT_%2FWellcome+Trust%2FUnited+Kingdom%5BGrants+and+Funding%5D&amp;sort=date&amp;sort_order=desc\">\n          110086/WT_/Wellcome Trust/United Kingdom\n        </a></li><li><a target=\"_blank\" title=\"All articles for grant 205228/Z/16/Z/Wellcome Trust (Wellcome)\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=205228%2FZ%2F16%2FZ%2FWellcome+Trust+%28Wellcome%29%5BGrants+and+Funding%5D&amp;sort=date&amp;sort_order=desc\">\n          205228/Z/16/Z/Wellcome Trust (Wellcome)\n        </a></li><li><a target=\"_blank\" title=\"All articles for grant 215477/WT_/Wellcome Trust/United Kingdom\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=215477%2FWT_%2FWellcome+Trust%2FUnited+Kingdom%5BGrants+and+Funding%5D&amp;sort=date&amp;sort_order=desc\">\n          215477/WT_/Wellcome Trust/United Kingdom\n        </a></li></ul><ul><li><a target=\"_blank\" title=\"All articles for grant PIII052/Wellcome Trust (Wellcome)\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=PIII052%2FWellcome+Trust+%28Wellcome%29%5BGrants+and+Funding%5D&amp;sort=date&amp;sort_order=desc\">\n          PIII052/Wellcome Trust (Wellcome)\n        </a></li><li><a target=\"_blank\" title=\"All articles for grant 209220/WT_/Wellcome Trust/United Kingdom\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=209220%2FWT_%2FWellcome+Trust%2FUnited+Kingdom%5BGrants+and+Funding%5D&amp;sort=date&amp;sort_order=desc\">\n          209220/WT_/Wellcome Trust/United Kingdom\n        </a></li><li><a target=\"_blank\" title=\"All articles for grant WT_/Wellcome Trust/United Kingdom\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=WT_%2FWellcome+Trust%2FUnited+Kingdom%5BGrants+and+Funding%5D&amp;sort=date&amp;sort_order=desc\">\n          WT_/Wellcome Trust/United Kingdom\n        </a></li><li><a target=\"_blank\" title=\"All articles for grant 214383/WT_/Wellcome Trust/United Kingdom\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=214383%2FWT_%2FWellcome+Trust%2FUnited+Kingdom%5BGrants+and+Funding%5D&amp;sort=date&amp;sort_order=desc\">\n          214383/WT_/Wellcome Trust/United Kingdom\n        </a></li><li><a target=\"_blank\" title=\"All articles for grant 098516/WT_/Wellcome Trust/United Kingdom\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=098516%2FWT_%2FWellcome+Trust%2FUnited+Kingdom%5BGrants+and+Funding%5D&amp;sort=date&amp;sort_order=desc\">\n          098516/WT_/Wellcome Trust/United Kingdom\n        </a></li><li><a target=\"_blank\" title=\"All articles for grant C62207/A24495/Cancer Research UK (CRUK)\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=C62207%2FA24495%2FCancer+Research+UK+%28CRUK%29%5BGrants+and+Funding%5D&amp;sort=date&amp;sort_order=desc\">\n          C62207/A24495/Cancer Research UK (CRUK)\n        </a></li><li><a target=\"_blank\" title=\"All articles for grant 223164/WT_/Wellcome Trust/United Kingdom\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=223164%2FWT_%2FWellcome+Trust%2FUnited+Kingdom%5BGrants+and+Funding%5D&amp;sort=date&amp;sort_order=desc\">\n          223164/WT_/Wellcome Trust/United Kingdom\n        </a></li><li><a target=\"_blank\" title=\"All articles for grant 108717/WT_/Wellcome Trust/United Kingdom\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=108717%2FWT_%2FWellcome+Trust%2FUnited+Kingdom%5BGrants+and+Funding%5D&amp;sort=date&amp;sort_order=desc\">\n          108717/WT_/Wellcome Trust/United Kingdom\n        </a></li><li><a target=\"_blank\" title=\"All articles for grant NIHR-PR-2016-06-004/DH | National Institute for Health Research (NIHR)\" href=\"https://pubmed.ncbi.nlm.nih.gov/?term=NIHR-PR-2016-06-004%2FDH+%7C+National+Institute+for+Health+Research+%28NIHR%29%5BGrants+and+Funding%5D&amp;sort=date&amp;sort_order=desc\">\n          NIHR-PR-2016-06-004/DH | National Institute for Health Research (NIHR)\n        </a></li></ul></div>\n    </div>\n  <div>\n    <h2>\n      LinkOut - more resources\n    </h2>\n    <ul><li><h3>Full Text Sources</h3><ul><li><a href=\"https://doi.org/10.1038/s41590-025-02301-9\" target=\"_blank\">\n                    Nature Publishing Group\n                  </a></li><li><a href=\"https://pmc.ncbi.nlm.nih.gov/articles/pmid/41152617/\" target=\"_blank\">\n                    PubMed Central\n                  </a></li></ul></li><li><h3>Medical</h3><ul><li><a href=\"https://medlineplus.gov/stemcells.html\" target=\"_blank\">\n                    MedlinePlus Health Information\n                  </a></li></ul></li></ul>\n  </div>\n  </div>",
  "author": "",
  "favicon": "https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/favicons/favicon-192.png",
  "source": "pubmed.ncbi.nlm.nih.gov",
  "published": "",
  "ttr": 760,
  "type": "website"
}